Results Are In! Stock Market Reaction to AstraZeneca Oxford Trial Results

from Dumb Money Live · host Dumb Money

Early reports revealed AstraZeneca's vaccine generates antibodies and T-Cells in the Oxford University phase 1 trial. The official data and results are set to be published today and could have a huge impact on the stock market.

What this episode covers

NOW PLAYING

0:00 41:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dumb Money Live?

This episode is 41 minutes long.

When was this Dumb Money Live episode published?

This episode was published on July 21, 2020.

What is this episode about?

Can I download this Dumb Money Live episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!